Panel Discussion: Brainstorming Combinations With CART, DDR, Cytokine-Based Therapies & Other Cell Engagers
Time: 9:30 am
day: Conference Day 2
Details:
- Discuss potential benefits and risks of combining cell engagers with alternate cancer therapies for personalized treatment strategies
- How can cell engager combinations be developed to reduce potential relapse while reducing the patient burden of treatment?
- Can these combinations mitigate T cell exhaustion to improve efficacy across cancer types and reduce patient burden?
